Key facts
- Anuncia Medical’s last known valuation is $26.0M (Feb 2025).
- It has raised $22.6M across 3 recorded rounds; the latest was Early Stage VC ($13.9M) in Aug 2024.
- Notable investors include Flinn Foundation, Pimlico Pond Investments, U.S. Boston Growth Capital, Alliance of Angels, Ariel Savannah Angel Partners — 11 tracked in total.
- Anuncia Medical has filed 9 Form Ds with the SEC since 2021, most recently Nov 2025 ($13.9M sold to 87 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Anuncia Medical
Funding rounds
3 roundsAbout Anuncia Medical
Developer of a ventricular system designed for the treatment of hydrocephalus. The company's neurotherapeutic device helps in cerebrospinal fluid management and neurocritical care of repeat revision brain surgeries and prevents complications of non-flowing shunts, enabling healthcare providers to treat the brain damage conditions of their patients.
- Sector
- Healthcare
- HQ
- Scottsdale, AZ, United States
- Founded
- 2018
- Employees
- 10
- Website
- anunciamedical.com/
- Ownership
- Privately Held (backing)
Anuncia Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anuncia Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anuncia Medical in its N-PORT filings yet. We sweep new filings monthly.